A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study will evaluate GKL‐006 injection in combination with nab‐paclitaxel andgemcitabine in patients with advanced pancreatic cancer. Phase I will primarily assesstolerability and safety, and will also evaluate preliminary efficacy and pharmacokineticand pharmacodynamic characteristics. Phase II will primarily evaluate efficacy, withfurther assessment of safety and pharmacokinetic and pharmacodynamic characteristics.
Epistemonikos ID: b06930aab8c41affcd7025b4d5b1e81f316dd3c6
First added on: Aug 20, 2026